Torthaí cuardaigh - Michael Boxer
- 1 - 9 toradh as 9 á dtaispeáint
-
1
The risk of Parkinson's disease in type 1 Gaucher disease de réir Gilberto Bultron, Katherine Kacena, Daniel S. Pearson, Michael Boxer, Ruhua Yang, Swati Sathe, Gregory M. Pastores, Pramod K. Mistry
Foilsithe / Cruthaithe 2010Artigo -
2
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program de réir James B. Bussel, Donald M. Arnold, Michael Boxer, Nichola Cooper, Jiřı́ Mayer, Hany Zayed, Sandra Tong, Anne‐Marie Duliège
Foilsithe / Cruthaithe 2019Artigo -
3
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia de réir Jeff P. Sharman, Michael Hawkins, Kathryn S. Kolibaba, Michael Boxer, Leonard M. Klein, Meihua Wu, Jing Hu, Steve Abella, Chris Yasenchak
Foilsithe / Cruthaithe 2015Artigo -
4
Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long‐term outcomes of therapy de réir Sarah M. Lo, Jun Liu, F. Chen, Gregory M. Pastores, James A. Knowles, Michael Boxer, Kirk Aleck, Pramod K. Mistry
Foilsithe / Cruthaithe 2011Artigo -
5
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients de réir Tamar H. Taddei, Katherine Kacena, Mei Yang, Ruhua Yang, Advitya Malhotra, Michael Boxer, Kirk Aleck, Gad Rennert, Gregory M. Pastores, Pramod K. Mistry
Foilsithe / Cruthaithe 2009Artigo -
6
Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia de réir Ralph V. Boccia, Nichola Cooper, Waleed Ghanima, Michael Boxer, Quentin A. Hill, Michelle Sholzberg, Michael D. Tarantino, Leslie Todd, Sandra Tong, James B. Bussel
Foilsithe / Cruthaithe 2020Artigo -
7
Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia de réir John C. Byrd, Joseph M. Flynn, Thomas J. Kipps, Michael Boxer, Kathryn S. Kolibaba, David Carlile, Guenter Fingerle-Rowson, Nicola Tyson, Jamie Hirata, Jeff P. Sharman
Foilsithe / Cruthaithe 2015Artigo -
8
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study de réir David J. Kuter, Kerry A. Rogers, Michael Boxer, Michael Y. Choi, Richy Agajanian, Donald M. Arnold, Catherine M. Broome, Joshua J. Field, Irina Murakhovskaya, Robert P. Numerof, Sandra Tong
Foilsithe / Cruthaithe 2022Artigo -
9
Comprehensively understanding fatigue in patients with myeloproliferative neoplasms de réir Robyn M. Scherber, Heidi E. Kosiorek, Zhenya Senyak, Amylou C. Dueck, Matthew M. Clark, Michael Boxer, Holly L. Geyer, Archie McCallister, Mary Cotter, Barbara Van Husen, Claire Harrison, Ruben A. Mesa
Foilsithe / Cruthaithe 2015Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Gastroenterology
Disease
Receptor
Tyrosine kinase
Adverse effect
Biology
Cancer
Chemotherapy
Chronic lymphocytic leukemia
Gene
Genetics
Glucocerebrosidase
Immune thrombocytopenia
Leukemia
Oncology
Platelet
Randomized controlled trial
Syk
Alternative medicine
Anemia
Autoimmune hemolytic anemia
Body mass index
Bone marrow
Bruton's tyrosine kinase
Cancer research
Chlorambucil
Chronic fatigue syndrome
Clinical endpoint